(AEE) Ameren - Overview
Sector: UtilitiesIndustry: Utilities - Regulated Electric | Exchange NYSE (USA) | Currency USD | Market Cap: 29.318m | Total Return 12.1% in 12m
Stock: Electricity, Natural Gas, Transmission, Generation
Total Rating 46
Risk 68
Buy Signal -0.26
| Risk 5d forecast | |
|---|---|
| Volatility | 17.6% |
| Relative Tail Risk | -2.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | 5.72 |
| Character TTM | |
|---|---|
| Beta | 0.159 |
| Beta Downside | 0.091 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.37% |
| CAGR/Max DD | 0.51 |
EPS (Earnings per Share)
Revenue
Description: AEE Ameren March 05, 2026
Ameren Corporation (AEE) is a U.S. public utility holding company. It operates regulated electric generation, transmission, and distribution, alongside natural gas transmission and distribution.
The companys operations are divided into four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. This multi-utility business model is common among large utility providers, offering diverse revenue streams.
Ameren generates electricity from a mix of sources, including coal, nuclear, natural gas, and renewables such as hydro, wind, methane, and solar. This diversified generation portfolio is typical for utilities balancing baseload power with environmental considerations.
Ameren serves residential, commercial, and industrial customers. To learn more about AEEs financial performance and valuation, consider exploring its profile on ValueRay.
Headlines to watch out for
- Missouri rate-regulated electric sales drive Amerens core revenue
- Illinois electric distribution revenue tied to regulatory approvals
- Natural gas transmission and distribution revenue impacts earnings
- Fuel and purchased power costs influence profitability
- Interest rate changes affect financing costs for infrastructure projects
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 1.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 2.04 > 1.0 |
| NWC/Revenue: -15.18% < 20% (prev -15.07%; Δ -0.11% < -1%) |
| CFO/TA 0.07 > 3% & CFO 3.35b > Net Income 1.46b |
| Net Debt (19.82b) to EBITDA (3.91b): 5.07 < 3 |
| Current Ratio: 0.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (273.7m) vs 12m ago 1.79% < -2% |
| Gross Margin: 38.14% > 18% (prev 0.48%; Δ 3.77k% > 0.5%) |
| Asset Turnover: 18.91% > 50% (prev 17.09%; Δ 1.81% > 0%) |
| Interest Coverage Ratio: 2.94 > 6 (EBITDA TTM 3.91b / Interest Expense TTM 776.0m) |
Altman Z'' 0.66
| A: -0.03 (Total Current Assets 2.57b - Total Current Liabilities 3.91b) / Total Assets 48.48b |
| B: 0.11 (Retained Earnings 5.29b / Total Assets 48.48b) |
| C: 0.05 (EBIT TTM 2.28b / Avg Total Assets 46.54b) |
| D: 0.15 (Book Value of Equity 5.29b / Total Liabilities 34.95b) |
| Altman-Z'' Score: 0.66 = B |
Beneish M -2.67
| DSRI: 1.06 (Receivables 1.19b/967.0m, Revenue 8.80b/7.62b) |
| GMI: 1.26 (GM 38.14% / 47.92%) |
| AQI: 1.01 (AQ_t 0.14 / AQ_t-1 0.14) |
| SGI: 1.15 (Revenue 8.80b / 7.62b) |
| TATA: -0.04 (NI 1.46b - CFO 3.35b) / TA 48.48b) |
| Beneish M-Score: -2.67 (Cap -4..+1) = A |
What is the price of AEE shares?
As of March 26, 2026, the stock is trading at USD 107.69 with a total of 1,463,532 shares traded.
Over the past week, the price has changed by -4.05%, over one month by -2.56%, over three months by +8.60% and over the past year by +12.14%.
Over the past week, the price has changed by -4.05%, over one month by -2.56%, over three months by +8.60% and over the past year by +12.14%.
Is AEE a buy, sell or hold?
Ameren has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy AEE.
- StrongBuy: 8
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the AEE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117 | 8.6% |
| Analysts Target Price | 117 | 8.6% |
AEE Fundamental Data Overview March 23, 2026
P/E Trailing = 19.8243
P/E Forward = 19.9203
P/S = 3.4613
P/B = 2.1877
P/EG = 2.7124
Revenue TTM = 8.80b USD
EBIT TTM = 2.28b USD
EBITDA TTM = 3.91b USD
Long Term Debt = 18.21b USD (from longTermDebt, last quarter)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 19.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.82b USD (from netDebt column, last quarter)
Enterprise Value = 49.13b USD (29.32b + Debt 19.83b - CCE 13.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 2.28b / Interest Expense TTM 776.0m)
EV/FCF = -61.34x (Enterprise Value 49.13b / FCF TTM -801.0m)
FCF Yield = -1.63% (FCF TTM -801.0m / Enterprise Value 49.13b)
FCF Margin = -9.10% (FCF TTM -801.0m / Revenue TTM 8.80b)
Net Margin = 16.55% (Net Income TTM 1.46b / Revenue TTM 8.80b)
Gross Margin = 38.14% ((Revenue TTM 8.80b - Cost of Revenue TTM 5.44b) / Revenue TTM)
Gross Margin QoQ = 27.95% (prev 36.64%)
Tobins Q-Ratio = 1.01 (Enterprise Value 49.13b / Total Assets 48.48b)
Interest Expense / Debt = 1.04% (Interest Expense 206.0m / Debt 19.83b)
Taxrate = 8.52% (136.0m / 1.60b)
NOPAT = 2.09b (EBIT 2.28b * (1 - 8.52%))
Current Ratio = 0.66 (Total Current Assets 2.57b / Total Current Liabilities 3.91b)
Debt / Equity = 1.48 (Debt 19.83b / totalStockholderEquity, last quarter 13.40b)
Debt / EBITDA = 5.07 (Net Debt 19.82b / EBITDA 3.91b)
Debt / FCF = -24.74 (negative FCF - burning cash) (Net Debt 19.82b / FCF TTM -801.0m)
Total Stockholder Equity = 12.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 1.46b / Total Assets 48.48b)
RoE = 11.48% (Net Income TTM 1.46b / Total Stockholder Equity 12.68b)
RoCE = 7.39% (EBIT 2.28b / Capital Employed (Equity 12.68b + L.T.Debt 18.21b))
RoIC = 6.41% (NOPAT 2.09b / Invested Capital 32.56b)
WACC = 4.28% (E(29.32b)/V(49.15b) * Re(6.54%) + D(19.83b)/V(49.15b) * Rd(1.04%) * (1-Tc(0.09)))
Discount Rate = 6.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 1.82%
[DCF] Fair Price = unknown (Cash Flow -801.0m)
EPS Correlation: 21.73 | EPS CAGR: -1.40% | SUE: 0.99 | # QB: 2
Revenue Correlation: 25.85 | Revenue CAGR: -1.40% | SUE: 0.85 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.11 | Chg7d=+0.014 | Chg30d=+0.007 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=5.38 | Chg7d=-0.000 | Chg30d=-0.000 | Revisions Net=+2 | Growth EPS=+0.5% | Growth Revenue=+3.6%
EPS next Year (2027-12-31): EPS=5.84 | Chg7d=-0.027 | Chg30d=+0.040 | Revisions Net=+3 | Growth EPS=+8.6% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 7.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = +0.6% (Analyst 3.5% - Implied 2.9%)
P/E Forward = 19.9203
P/S = 3.4613
P/B = 2.1877
P/EG = 2.7124
Revenue TTM = 8.80b USD
EBIT TTM = 2.28b USD
EBITDA TTM = 3.91b USD
Long Term Debt = 18.21b USD (from longTermDebt, last quarter)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 19.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 19.82b USD (from netDebt column, last quarter)
Enterprise Value = 49.13b USD (29.32b + Debt 19.83b - CCE 13.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 2.28b / Interest Expense TTM 776.0m)
EV/FCF = -61.34x (Enterprise Value 49.13b / FCF TTM -801.0m)
FCF Yield = -1.63% (FCF TTM -801.0m / Enterprise Value 49.13b)
FCF Margin = -9.10% (FCF TTM -801.0m / Revenue TTM 8.80b)
Net Margin = 16.55% (Net Income TTM 1.46b / Revenue TTM 8.80b)
Gross Margin = 38.14% ((Revenue TTM 8.80b - Cost of Revenue TTM 5.44b) / Revenue TTM)
Gross Margin QoQ = 27.95% (prev 36.64%)
Tobins Q-Ratio = 1.01 (Enterprise Value 49.13b / Total Assets 48.48b)
Interest Expense / Debt = 1.04% (Interest Expense 206.0m / Debt 19.83b)
Taxrate = 8.52% (136.0m / 1.60b)
NOPAT = 2.09b (EBIT 2.28b * (1 - 8.52%))
Current Ratio = 0.66 (Total Current Assets 2.57b / Total Current Liabilities 3.91b)
Debt / Equity = 1.48 (Debt 19.83b / totalStockholderEquity, last quarter 13.40b)
Debt / EBITDA = 5.07 (Net Debt 19.82b / EBITDA 3.91b)
Debt / FCF = -24.74 (negative FCF - burning cash) (Net Debt 19.82b / FCF TTM -801.0m)
Total Stockholder Equity = 12.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 1.46b / Total Assets 48.48b)
RoE = 11.48% (Net Income TTM 1.46b / Total Stockholder Equity 12.68b)
RoCE = 7.39% (EBIT 2.28b / Capital Employed (Equity 12.68b + L.T.Debt 18.21b))
RoIC = 6.41% (NOPAT 2.09b / Invested Capital 32.56b)
WACC = 4.28% (E(29.32b)/V(49.15b) * Re(6.54%) + D(19.83b)/V(49.15b) * Rd(1.04%) * (1-Tc(0.09)))
Discount Rate = 6.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 1.82%
[DCF] Fair Price = unknown (Cash Flow -801.0m)
EPS Correlation: 21.73 | EPS CAGR: -1.40% | SUE: 0.99 | # QB: 2
Revenue Correlation: 25.85 | Revenue CAGR: -1.40% | SUE: 0.85 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.11 | Chg7d=+0.014 | Chg30d=+0.007 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=5.38 | Chg7d=-0.000 | Chg30d=-0.000 | Revisions Net=+2 | Growth EPS=+0.5% | Growth Revenue=+3.6%
EPS next Year (2027-12-31): EPS=5.84 | Chg7d=-0.027 | Chg30d=+0.040 | Revisions Net=+3 | Growth EPS=+8.6% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.9% (Discount Rate 7.9% - Earnings Yield 5.0%)
[Growth] Growth Spread = +0.6% (Analyst 3.5% - Implied 2.9%)